US 7071224
Diphenylmethyl compounds useful as muscarinic receptor antagonists
granted A61KA61K31/40A61K31/445
Quick answer
US patent 7071224 (Diphenylmethyl compounds useful as muscarinic receptor antagonists) held by Theravance, Inc. expires Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Jul 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/40, A61K31/445, A61K9/0075, A61K9/0078